Primary Record
863329-66-2
- In stock
- 1,950 g
- Purity
- 99.5 %
- CAS
- 863329-66-2
Compound Identifiers & Properties
- CAS
- 863329-66-2
- PubChem CID
- 11311503
- SMILES
- C[C@]1([C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)CO)O)F
- Canonical SMILES
- C[C@@]1(F)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(=O)[nH]c1=O
Names & Synonyms
- 863329-66-2
- PSI-6206
- 2'-Deoxy-2'-fluoro-2'-C-methyluridine
- SOFOSBUVIR
- (2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine
- Ro-2433
- MFCD19982668
- Sofosbuvir Impurity 79
- C10H13FN2O5
- PSI6206
- RefChem:418387
- Sofosbuvir IP Impurity D
- UNII-44V7045CXS
- (2'R)-2'-Deoxy-2'-fluoro-2'-methyl-uridine
- 44V7045CXS
- Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)-
- GS-331007
- SCHEMBL768095
- CHEMBL510394
- orb1306444
- URI002
- Sofosbuvir Nucleoside Derivative
- 2'-deoxy-2'-fluoro-2'-methyluridine
- SCHEMBL28438534
- AMMD00046
- RO 2433
- DTXSID30462011
- Sofosbuvir metabolite GS331007
- ARKKGZQTGXJVKW-VPCXQMTMSA-N
- GLXC-05160
- Sofosbuvir Metabolites GS331007
- AMX10218
- EX-A2144
- PSI6206?
- GS 331007
- 2-deoxy-2-fluoro-2-C-methyluridine
- ARD168992
- NSC796320
- RO2433
- s5307
- ZINC40380308
- AKOS016008997
- ACN-028562
- AM84275
- CCG-267052
- CM14184
- CS-0630
- CS-O-30475
- EBC-656141
- ND29433
- NSC-796320
- 1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
- CID11311503
- NCGC00379006-04
- (2R)-2-Deoxy-2-fluoro-2-methyluridine
- AC-27383
- AS-20013
- BC296244
- BP-58616
- GS-331007 (PSI-6206)
- GS331007
- HY-15236
- SC-50506
- SY034345
- 2'-deoxy-2'-fluoro-2'-C-methyl-uridine
- 2/'-Deoxy-2/'-fluoro-2/'-methyluridine
- AJ-101648
- A8189
- FT-0771272
- Uridine, 2'-C-methyl-2'-Fluoro-2'-deoxy
- Z3630
- J2.995.016D
- A11530
- P12685
- RO 2433;RO2433;RO-2433
- W-5822
- (2'R)-2'-deoxy-2'-fluoro-2'-C-methyluridine
- 1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyl-tetrahydrofuran-2-yl)pyrimidine-2,4-dione
- 1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
- |A-D-2'-deoxy-2'-|A-fluoro-2'C-methyluridine
- 2 beta-Methyl-2 -fluoro-2 -deoxyuridine
- A847977
- F238618
- Uridine,2'-deoxy-2'-fluoro-2'-methyl-,(2'R)
- beta-D-2'-deoxy-2'-alpha-F-2'-beta-C-methyluridine
- Q27258768
- (2 R)-2 -Fluoro-2 -methyl-2 -deoxyuridine
- (2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine / PSI-6206
- B2693-459960
- 1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyl-tetrahydrofuran-2-yl]pyrimidine-2,4-dione
- 1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidine-2,4-dione
- (2 inverted exclamation mark R)-2 inverted exclamation mark -Deoxy-2 inverted exclamation mark -fluoro-2 inverted exclamation mark -methyluridine
- [(2R,3R,4R,5R)-5-(2,4-Dioxo-1,2,3,4-tetrahydropyrimidine-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl]methanol
- 1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; GS 331007; PSI-6206; RO 2433; Sofosbuvir Nucleoside Derivative; Sofosbuvir metabolite
- 1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4-(1H,3H)-dione, 98% - 1G 1g
- 1-((2r,3r,4r,5r)-3-fluoro-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione
- 1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyl-oxolan-2-yl]pyrimidine-2,4-dione
- 1-[(2R,3R,4R,5R)-3-FLUORO-4-HYDROXY-5-(HYDROXYMETHYL)-3-METHYLOXOLAN-2-YL]-3H-PYRIMIDINE-2,4-DIONE
- 1-[(2R,3R,4R,5R)-3-FLUORO-4-HYDROXY-5-(HYDROXYMETHYL)-3-METHYLTETRAHYDRO-2-FURANYL]-2,4(1H,3H)-PYRIMIDINEDIONE
- 1-[(2R,3R,4R,5R)-4-Fluoro-3-hydroxy-2-hydroxymethyl-4-methyltetrahydrofuran-5-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
- 2'-Deoxy-2'-fluoro-2'-C-methyluridine; Uridine, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)-; UNII-44V7045CXS
- 2-deoxy-2-fluoro-2-C -Methyluridine; 1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
- U7I